91 related articles for article (PubMed ID: 26427385)
1. Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis.
Corrêa MF; Fernandes JP
Curr Protein Pept Sci; 2016; 17(3):213-9. PubMed ID: 26427385
[TBL] [Abstract][Full Text] [Related]
2. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis.
Shi W; Zhang X; Jiang X; Yuan H; Lee JS; Barry CE; Wang H; Zhang W; Zhang Y
Science; 2011 Sep; 333(6049):1630-2. PubMed ID: 21835980
[TBL] [Abstract][Full Text] [Related]
3. Pyrazinoic Acid Inhibits a Bifunctional Enzyme in Mycobacterium tuberculosis.
Njire M; Wang N; Wang B; Tan Y; Cai X; Liu Y; Mugweru J; Guo J; Hameed HMA; Tan S; Liu J; Yew WW; Nuermberger E; Lamichhane G; Liu J; Zhang T
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438933
[TBL] [Abstract][Full Text] [Related]
4. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304
[TBL] [Abstract][Full Text] [Related]
5. A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide-resistant Mycobacterium tuberculosis.
Shahab M; de Farias Morais GC; Akash S; Fulco UL; Oliveira JIN; Zheng G; Akter S
J Cell Mol Med; 2024 Apr; 28(8):e18279. PubMed ID: 38634203
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamidase/pyrazinamidase of Mycobacterium tuberculosis forms homo-dimers stabilized by disulfide bonds.
Rueda D; Sheen P; Gilman RH; Bueno C; Santos M; Pando-Robles V; Batista CV; Zimic M
Tuberculosis (Edinb); 2014 Dec; 94(6):644-8. PubMed ID: 25199451
[TBL] [Abstract][Full Text] [Related]
7. Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide.
Fyfe PK; Rao VA; Zemla A; Cameron S; Hunter WN
Angew Chem Int Ed Engl; 2009; 48(48):9176-9. PubMed ID: 19859929
[No Abstract] [Full Text] [Related]
8. Laryngopharyngeal tuberculosis: a rare entity in the era of antibiotics.
Abreu VS; Coelho FL; Cardoso J; Pinto JF
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35705303
[No Abstract] [Full Text] [Related]
9. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages.
Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E
Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493
[TBL] [Abstract][Full Text] [Related]
10. Recognizing drug targets using evolutionary information: implications for repurposing FDA-approved drugs against Mycobacterium tuberculosis H37Rv.
Ramakrishnan G; Chandra NR; Srinivasan N
Mol Biosyst; 2015 Dec; 11(12):3316-31. PubMed ID: 26429199
[TBL] [Abstract][Full Text] [Related]
11. Efflux pump inhibitors: targeting mycobacterial efflux systems to enhance TB therapy.
Pule CM; Sampson SL; Warren RM; Black PA; van Helden PD; Victor TC; Louw GE
J Antimicrob Chemother; 2016 Jan; 71(1):17-26. PubMed ID: 26472768
[TBL] [Abstract][Full Text] [Related]
12. Peptidoglycan synthesis in Mycobacterium tuberculosis is organized into networks with varying drug susceptibility.
Kieser KJ; Baranowski C; Chao MC; Long JE; Sassetti CM; Waldor MK; Sacchettini JC; Ioerger TR; Rubin EJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13087-92. PubMed ID: 26438867
[TBL] [Abstract][Full Text] [Related]
13. Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis.
Maiga MC; Ahidjo BA; Maiga M; Bishai WR
Antimicrob Agents Chemother; 2015 Dec; 59(12):7888-90. PubMed ID: 26438491
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of putative drug resistance genes in Mycobacterium tuberculosis clinical isolates.
González-Escalante L; Peñuelas-Urquides K; Said-Fernández S; Silva-Ramírez B; Bermúdez de León M
FEMS Microbiol Lett; 2015 Dec; 362(23):fnv194. PubMed ID: 26454220
[TBL] [Abstract][Full Text] [Related]
15. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
[TBL] [Abstract][Full Text] [Related]
16. Assembly of the Mycobacterial Cell Wall.
Jankute M; Cox JA; Harrison J; Besra GS
Annu Rev Microbiol; 2015; 69():405-23. PubMed ID: 26488279
[TBL] [Abstract][Full Text] [Related]
17. Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis.
Rabodoarivelo MS; Imperiale B; Andrianiavomikotroka R; Brandao A; Kumar P; Singh S; Ferrazoli L; Morcillo N; Rasolofo V; Palomino JC; Vandamme P; Martin A
PLoS One; 2015; 10(10):e0139382. PubMed ID: 26431352
[TBL] [Abstract][Full Text] [Related]
18. E1 of α-ketoglutarate dehydrogenase defends Mycobacterium tuberculosis against glutamate anaplerosis and nitroxidative stress.
Maksymiuk C; Balakrishnan A; Bryk R; Rhee KY; Nathan CF
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):E5834-43. PubMed ID: 26430237
[TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide resistance determined by liquid culture at low pH better correlates with genetic mutations in MDR tuberculosis isolates.
Pang Y; Wang Z; Zheng H; Song Y; Wang Y; Zhao Y
J Microbiol Methods; 2015 Dec; 119():142-4. PubMed ID: 26506283
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
